
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial. Nourbakhsh B, Revirajan N, Morris B, et al. Lancet Neurol 2021; 20:38-48. Abstract Background Methylphenidate, modafinil, and amantadine are commonly prescribed medications for alleviating fatigue in multiple sclerosis; however, the evidence supporting their efficacy is sparse […]
Are the drug treatments of MS related fatigue effective? — Neurochecklists Blog